Matthew Gall - Chief Financial Officer, Iteos Therapeutics, Inc

As of October 12, 2021


Matthew Gall Net Worth

  • Net worth is estimated to be at least $135.95K
  • Owns at least 5,000 units of Iteos Therapeutics, Inc stock

Matthew Gall Trading

  • Largest purchase of shares was 5,000 units , worth over $130.45K on June 16, 2021
  • In total has made about 4 transactions over 8 months
  • Usually trades in June, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Matthew Gall Mailing Address

  • Mailing address is C/o Iteos Therapeutics, Inc. 139 Main Street Cambridge MA 02142 MA

Iteos Therapeutics, Inc Insider Trading

  • The most recent transaction was 56,770 units sold on October 14, 2021 by Mpm Bioventures Lp, Mpm Bioventures Llc and Mpm Bioventures GP Llc worth over $1.54M
  • In the last year, insiders at Iteos Therapeutics, Inc sold an estimated value of $55.12M and bought an estimated value of $108.29M
  • The most active traders are Ansbert Gadicke,  Mpm Bioventures Lp,  and Bioimpact Capital Llc
  • Insider trading is most common in September, with the busiest year in 2021

iTeos Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1